1. Home
  2. HCM vs UE Comparison

HCM vs UE Comparison

Compare HCM & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • UE
  • Stock Information
  • Founded
  • HCM 2000
  • UE 2014
  • Country
  • HCM Hong Kong
  • UE United States
  • Employees
  • HCM N/A
  • UE N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • UE Real Estate
  • Sector
  • HCM Health Care
  • UE Finance
  • Exchange
  • HCM Nasdaq
  • UE Nasdaq
  • Market Cap
  • HCM 2.6B
  • UE 2.5B
  • IPO Year
  • HCM N/A
  • UE N/A
  • Fundamental
  • Price
  • HCM $17.44
  • UE $20.42
  • Analyst Decision
  • HCM
  • UE Buy
  • Analyst Count
  • HCM 0
  • UE 3
  • Target Price
  • HCM N/A
  • UE $22.67
  • AVG Volume (30 Days)
  • HCM 57.4K
  • UE 1.0M
  • Earning Date
  • HCM 08-07-2025
  • UE 10-29-2025
  • Dividend Yield
  • HCM N/A
  • UE 3.68%
  • EPS Growth
  • HCM N/A
  • UE N/A
  • EPS
  • HCM 0.53
  • UE 0.84
  • Revenue
  • HCM $602,197,000.00
  • UE $461,043,000.00
  • Revenue This Year
  • HCM $2.73
  • UE $6.41
  • Revenue Next Year
  • HCM $17.33
  • UE $4.02
  • P/E Ratio
  • HCM $6.26
  • UE $24.49
  • Revenue Growth
  • HCM N/A
  • UE 8.59
  • 52 Week Low
  • HCM $11.51
  • UE $15.66
  • 52 Week High
  • HCM $21.50
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • HCM 60.43
  • UE 48.73
  • Support Level
  • HCM $15.51
  • UE $20.32
  • Resistance Level
  • HCM $18.30
  • UE $21.29
  • Average True Range (ATR)
  • HCM 0.35
  • UE 0.36
  • MACD
  • HCM 0.29
  • UE -0.07
  • Stochastic Oscillator
  • HCM 76.18
  • UE 12.30

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: